Cite
Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
MLA
Akbar Khan, et al. “Long-Term Safety and Tolerability of Long-Acting Injectable Risperidone in Patients with Schizophrenia or Schizoaffective Disorder.” European Neuropsychopharmacology, vol. 17, Jan. 2007, pp. 138–44. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2006.08.004.
APA
Akbar Khan, Jean-Pierre Lindenmayer, Stuart Kushner, Ilse Van Hove, & Mariëlle Eerdekens. (2007). Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder. European Neuropsychopharmacology, 17, 138–144. https://doi.org/10.1016/j.euroneuro.2006.08.004
Chicago
Akbar Khan, Jean-Pierre Lindenmayer, Stuart Kushner, Ilse Van Hove, and Mariëlle Eerdekens. 2007. “Long-Term Safety and Tolerability of Long-Acting Injectable Risperidone in Patients with Schizophrenia or Schizoaffective Disorder.” European Neuropsychopharmacology 17 (January): 138–44. doi:10.1016/j.euroneuro.2006.08.004.